Clinical Trial

Development and Validation of Microbiota and Metabolite-based Prediction Model for Recurrence of High-risk Colorectal Polyps After Polypectomy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 1, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The characteristics of the intestinal microbiota in high-risk colorectal polyp recurrence and their relationship with disease pathogenesis have not yet been fully elucidated. This study aims to analyze the microbial community characteristics in the intestinal mucosal tissue of patients after polypectomy with recurrence of colorectal polyps. Additionally, this research holds significant importance for understanding the etiology of adenoma recurrence and develop a microbiota and metabolite-based predicting tool.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-26.
Trial Details
NCT Number NCT06957626
Lead Sponsor Peking Union Medical College Hospital
Conditions Colorectal Polyp, Colorectal Cancer Recurrent, Colorectal Adenoma
Enrollment 150 participants
Start Date 2023-04-25
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-01